Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 422,765 | 239,616 | 270,391 | 230,784 | 241,179 |
| Marketable Securities | 135,618 | 122,250 | 47,553 | 135,563 | 164,359 |
| Receivables | 8,695 | 9,136 | N/A | N/A | N/A |
| Inventories | 2,735 | 151 | N/A | N/A | N/A |
| TOTAL | $580,996 | $383,158 | $326,034 | $375,274 | $413,291 |
| Non-Current Assets | |||||
| PPE Net | 904 | 196 | 185 | 208 | 213 |
| Intangibles | 16,216 | 16,802 | 0 | 0 | 0 |
| Other Non-Current Assets | 2,691 | 281 | 426 | 566 | 675 |
| TOTAL | $19,811 | $17,279 | $611 | $774 | $888 |
| Total Assets | $600,807 | $400,437 | $326,645 | $376,048 | $414,179 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,017 | 6,444 | 4,780 | 2,576 | 3,391 |
| Accrued Expenses | 35,189 | 87,072 | 24,759 | 26,524 | 20,647 |
| TOTAL | $39,745 | $93,706 | $29,839 | $29,508 | $24,475 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,462 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 2,538 | 0 | 0 | 0 | 77 |
| TOTAL | $5,599 | $N/A | $N/A | $N/A | $77 |
| Total Liabilities | $45,344 | $93,706 | $29,839 | $29,508 | $24,552 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 100,846 | 87,760 | 87,390 | 87,385 | 87,043 |
| Common Shares | 10 | 9 | 9 | 9 | 9 |
| Retained earnings | -488,367 | -525,404 | -520,997 | -458,585 | -404,074 |
| Other shareholders' equity | -6 | -22 | -5 | 9 | -7 |
| TOTAL | $555,463 | $306,731 | $296,806 | $346,540 | $389,627 |
| Total Liabilities And Equity | $600,807 | $400,437 | $326,645 | $376,048 | $414,179 |